1-6 of 6 results for subject:Fractures
Librarians' tools
- Search time
- 0.143 seconds
- Solr query time
- 0.002 seconds
- Search query
- subject:Fractures
- We searched for
- subject_t:Fractures OR subject_ses:345701
Type
House
Session
Year
Department
Member
Primary member
Answering member
Legislative stage
Legislation
Subject
Publisher
To ask the Secretary of State for Health, what discussions his Department has had with clinical bodies on the use of 3D printer technology on people with fractures.
To ask the Secretary of State for Health, what discussions his Department has had with clinical bodies on the use of 3D printer technology on people with fractures.
There have been no recent discussions between the Department and clinical bodies on the use of 3D printer technology on people with fractures.
To ask the Secretary of State for Health, what discussions he has had with medical companies on the potential merits of using 3D printers to help those with broken bones.
To ask the Secretary of State for Health, what discussions he has had with medical companies on the potential merits of using 3D printers to help those with broken bones.
There have been no recent discussions between my Rt. hon. Friend the Secretary of State for Health and medical companies on the use of 3D printers in relation to broken bones.
To ask the Secretary of State for Health, how many applications for funding for treatment by the Exogen Ultrasound Bone Healing System have been approved for NHS patients in (a) South Tees NHS Trust, (b) the North East and (c) England since May 2015.
To ask the Secretary of State for Health, how many applications for funding for treatment by the Exogen Ultrasound Bone Healing System have been approved for NHS patients in (a) South Tees NHS Trust, (b) the North East and (c) England since May 2015.
Responsibility for commissioning and funding treatment using the Exogen Ultrasound Bone Healing System lies with local clinical commissioning groups (CCGs).
Information on funding applications for this treatment is not collected centrally and no assessment has been made of any regional disparity in successful funding applications.
CCGs are expected to take account of guidance from the National Institute for Health and Care Excellence and the health needs and priorities of their local populations, when determining the range and level of services they provide.
To ask the Secretary of State for Health, if he will take steps to ensure that Exogen Ultrasound Bone Healing System treatment is funded by the NHS for repairs and fusions of joints rather than just for larger bones.
To ask the Secretary of State for Health, if he will take steps to ensure that Exogen Ultrasound Bone Healing System treatment is funded by the NHS for repairs and fusions of joints rather than just for larger bones.
Responsibility for commissioning and funding treatment using the Exogen Ultrasound Bone Healing System lies with local clinical commissioning groups (CCGs).
Information on funding applications for this treatment is not collected centrally and no assessment has been made of any regional disparity in successful funding applications.
CCGs are expected to take account of guidance from the National Institute for Health and Care Excellence and the health needs and priorities of their local populations, when determining the range and level of services they provide.
To ask the Secretary of State for Health, what assessment he has made of the level of regional disparity in successful funding applications for Exogen Ultrasound Bone Healing System treatment for NHS patients.
To ask the Secretary of State for Health, what assessment he has made of the level of regional disparity in successful funding applications for Exogen Ultrasound Bone Healing System treatment for NHS patients.
Responsibility for commissioning and funding treatment using the Exogen Ultrasound Bone Healing System lies with local clinical commissioning groups (CCGs).
Information on funding applications for this treatment is not collected centrally and no assessment has been made of any regional disparity in successful funding applications.
CCGs are expected to take account of guidance from the National Institute for Health and Care Excellence and the health needs and priorities of their local populations, when determining the range and level of services they provide.
To ask Her Majesty’s Government, in the light of the statement in the Executive Summary of the Water fluoridation: Health monitoring report for England 2014 that there is "no evidence of a difference in the rate of hip fractures between fluoridated and non-fluoridated areas", what account Public Health England took...
To ask Her Majesty’s Government, in the light of the statement in the Executive Summary of the Water fluoridation: Health monitoring report for England 2014 that there is "no evidence of a difference in the rate of hip fractures between fluoridated and non-fluoridated areas", what account Public Health England took...
The possible effects of fluoride in water have been extensively studied and reviewed over the last 50 years. In the United Kingdom the most recent review prior to the publication of Public Health England’s (PHE) Health Monitoring Report was undertaken by the National Health Service Centre for Reviews and Dissemination based at the University of York and published in 2000. The Medical Research Council subsequently, in 2002, reported to the Department of Health its advice on future research priorities. The US National Research Council reported in 2006 and the Australian National Health and Medical Research Council reported in 2007. PHE drew on these authoritative sources in selecting a number of indicators of health conditions for inclusion in the 2014 water fluoridation health monitoring report.
The chosen indicators of various health conditions were selected based on the evidence base, theoretical plausibility, potential impact on population health, the quality and availability of data, and the validity of the indicator. The selected indicators will be reviewed for future reports in the light of emerging evidence.
The article by KK Cheng et al did not provide any new evidence regarding hip fractures, but comments on the chance of detecting an increased risk of hip fracture for a speculated odds ratio of 1.2 in a previous study by Hiller et al. 2000. This only refers to a single study and it is important to consider the overall weight of evidence.
The overall weight of evidence and the consensus of opinion from authoritative reviews do not indicate that a drinking water concentration of 1 part fluoride per million parts of water presents an increased risk of hip fracture.
A more recent review of potential health effects from water fluoridation was published in 2015 by the Irish Research Board. The report concluded that a summary of the existing literature indicates that the relationship between fluoride in drinking water and bone health is inconsistent, with no definitive proof of protective or harmful effects.